All our
news

Discuss, meet & share

Press releases

Intrasense announces the CE marking of Liflow®’s new version enhanced by AI dedicated to the liver

16 December 2024

Intrasense (FR0011179886 - ALINS), medical imaging software solutions expert and developer of Myrian® et Liflow®, is proud to announce that the Lilfow® solution obtained the CE certification under MDR1, integrating a new AI algorithm for the detection of focal liver lesions developed in collaboration with Guerbet (trade name: DUOnco™ Liver). This new version is being deployed on clinical sites.

See the press release

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging

3 December 2024

Guerbet (FR0000032526 GBT) worldwide expert in contrast agents and medical imaging solutions, Intrasense (FR0011179886 - ALINS), expert in medical imaging software solutions and developer of Myrian® and Liflow®, Gustave Roussy, 1st cancerology centre in France and Europe and Angers University Hospital (« Partners ») announce they have received €5.9M in funding from Bpifrance’s “Innovation in Medical Imaging” call for proposals. The Oncology Assistant (trade name: Liflow®) project, carried by the four Partners uses AI (artificial intelligence) to facilitate and optimize the follow-up of cancer patients. It benefits from public funding to ensure its future development.

See the press release

Intrasense announces the CE marking of Myrian 2.13, enriched by the new version of Guerbet’s prostate AI

20 November 2024

Intrasense (FR0011179886 - ALINS), medical imaging software expert and developer of Myrian® and Liflow®, is proud to announce that the Myrian® 2.13 platform has obtained the CE marking under MDR1, including a major new version of the prostate AI developed by Guerbet, Veolity® LungCAD AI developed by MeVis Medical Solutions AG and Icobrain™ AI developed by Icometrix.

See the press release

Intrasense announces its participation in RSNA 2024, the world's leading medical imaging congress

6 November 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announces its participation in the RSNA 2024 international imaging congress. Intrasense will be showcasing its new Liflow® solution, as well as the innovations of the new version of Myrian®, on the stand of its partner Guerbet, symbolizing a collaboration serving excellence in medical imaging at a global level.

See the press release

Liflow®, a solution dedicated to oncology imaging, wins the JFR 2024 Innovation Prize in the “Healthcare IT and AI” category

30 September 2024

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and the developer of Myrian® and Liflow®, is proud to announce that its Liflow® solution has been awarded the Prix Innovation JFR (Journées Francophones de la Radiologie) 2024 in the “Healthcare IT and AI” category.

See the press release
1 2 3 24

Our
conferences

JFR 2024

From 10/04 to 10/07/2024.
Congress Center - Paris - France
Details

SIRM 2024

From 06/20 to 06/23/2024
Allianz MiCo - Milan - Italy
Details

SERAM 2024

From 05/22 to 05/25/2024
International Convention Center - Barcelona - Spain
Details

Röko 2024

From 08/05 to 10/05/2024
RheinMain CongressCenter - Wiesbaden - Germany
Details

ECR 2024

From 26/02 to 02/03/2024.
Exhibition Congress Center - Vienna - Austria
Details

RSNA 2023

From 05/22 to 05/25/2024
International Convention Center - Barcelona - Spain
Details

French days of radiology 2023

From 07/10 to 10/10/2022.
Congress Center - Paris - France
Details

AFIB Congress

From 28/09 to 30/09/2022
The Congress of Biomedical Engineers - Lille
Details

WebinarsPodcasts

Presentation of annual results for 2023 and ambitions for 2024

22 April 2024
Intrasense presents its 2023 annual results.Discover in this webinar the progress of Intrasense's medical imaging solutions, its 2024 objectives and ambitions.
Watch the video

Presentation of the half-yearly financial results 2022

21 October 2022
To coincide with the publication of its half-year results for 2022, Intrasense will provide an update on its latest developments.
Watch the video

Presentation of 2021 annual results and 2022 ambitions

14 March 2022
On the occasion of the publication of its 2021 annual results, Intrasense will provide an update on its latest developments.
Watch the video

Demo of the new COVID-19 dedicated protocol

2 April 2020
This protocol offers numerous clinical advantages, particularly in terms of screening, pathological stage analysis and pathological progression.
Watch the video

Our
articles

Disappearing artificial intelligence

At a time when everyone in medical imaging only talks about artificial intelligence, our only goal is to make it invisible. The convergence of reliable artificial intelligence (AI) algorithms and the growing body of image data have created fertile ground for its use in solving the problems facing radiologists and clinicians. Press articles and communication […]
READ THE ARTICLE

Brain perfusion CT, a key tool in the assessment of stroke

Stroke is a consequence of the obstruction or the rupture of a vessel supplying the brain, results in a neurological deficit of sudden installation, which can concern various aspects including motor ability, language, sensitivity or even vision just to name the most common symptoms. Manifestations vary and depend on the site of the brain injury. […]
READ THE ARTICLE

Is teleradiology the future of radiology?

Teleradiology has evolved from a potential threat to a more widely accepted traditional medical imaging technique and improved access to care for large numbers of patients. Many departments now use teleradiology or external reading of exams. However, there are still some obstacles to allow him to reach his full potential. The role of teleradiology in […]
READ THE ARTICLE

Do you want to receive our news in real time?

Subscribe